Surveillance of Bacterial Antibiotic Resistance in Community Care and Long-Term Care Facilities. Key Findings for 2025

In 2025, the participation of private clinical laboratories increased, accounting for 52.4% of all French private clinical laboratories (compared to 44.6% in 2024). Resistance to third-generation cephalosporins (3GCS) in Escherichia coli continued to rise, reaching 5.1% in private labs and 10% in nursing homes, without meeting the targets set by the National Strategy for Infection Prevention and Antibiotic Resistance (SNPIA) for 2027 (<3% in community settings, <10% in nursing homes). In contrast, resistance to fluoroquinolones has decreased (9% in the community, 11.6% in nursing homes), meeting the established targets (<10% in the community, <18% in nursing homes). Resistance to EPCs remains low and is below the SNPIA target (<0.5%), but has been rising steadily since 2018.

Author(s): Lemenand Olivier, Thibaut-Jovelin Sonia, Coeffic Thomas, Birgand Gabriel

Publishing year: 2026

Pages: 16 p.

Collection: Monitoring Data

In relation to

Our latest news

Appel à candidatures d'experts pour le remplacement d’un membre « sage-femme » du Comité national d'experts sur la mortalité maternelle (CNEMM)

news

Call for Nominations to Fill Vacancies on the National Reference Centers...

news

Public Health France Conference: November 9, 2026

news

Shamonda Virus: First Human Case Detected in France—What Do We Know?